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ABSTRACT
Mining massive amounts of transcript data for alter-
native splicing information is paramount to help
understand how the maturation of RNA regulates
gene expression. We developed an algorithm to
cluster transcript data to annotated genes to
detect unannotated splice variants. A higher
number of alternatively spliced genes and isoforms
were found compared to other alternative splicing
databases. Comparison of human and mouse data
revealed a marked increase, in human, of splice
variants incorporating novel exons and retained
introns. Previously unannotated exons were
validated by tiling array expression data and
shown to correspond preferentially to novel first
exons. Retained introns were validated by tiling
array and deep sequencing data. The majority of
retained introns were shorter than 500nt and had
weak polypyrimidine tracts. A subset of retained
introns matching small RNAs and displaying a high
GC content suggests a possible coordination
between splicing regulation and production of
noncoding RNAs. Conservation of unannotated
exons and retained introns was higher in horse,
dog and cow than in rodents, and 64% of exon se-
quences were only found in primates. This analysis
highlights previously bypassed alternative splice
variants, which may be crucial to deciphering more
complex pathways of gene regulation in human.
INTRODUCTION
The overwhelming volume of currently available biologic-
al sequence data requires the creation of automated pro-
cedures for mining databases containing vast amounts of
data. For the human genome alone, over 8 million
transcribed sequences have been deposited in GenBank
(1). An important piece of information is the identiﬁcation
of all alternatively spliced transcripts generated by each
gene. Alternative splicing has evolved as a predominant
mechanism in expanding the proteomic complexity
encoded in a limited number of genes (2,3), a source of
variation that is further exponentiated by the combinator-
ial possibilities inherent in the modular nature of protein
complexes. Alternative splicing occurs in response to a
wide range of stimuli and has been shown to be
tissue-speciﬁc, developmental stage-speciﬁc and
disease-speciﬁc (4). Early studies based on the large-scale
analysis of cDNAs and expressed sequence tags (ESTs)
indicate that more than 60% of human genes undergo
alternative splicing (5), while microarray analyses have
led to an increase in this estimate to between 73% (6)
and 80% (7). More recently, high-throughput sequencing
technologies are revealing that 92–94% of human genes
undergo alternative splicing (8–10).
However, in recent years, it has become apparent that
many of the alternatively spliced isoforms in a gene do not
produce any protein. Several lines of evidence indicate
that post-transcriptional regulation through alternative
splicing involving non-protein-coding transcripts un-
doubtedly constitutes an important mechanism for the
control of gene expression (11,12). Mechanisms of this
nature include regulated unproductive splicing and
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(NMD) (13,14).
In the process of exploring alternatively spliced tran-
scripts in several model organisms, we came to realize
that there appeared to be greater amounts of apparently
non-protein-coding alternative transcripts containing
intron retentions or new exons in human genes than in
orthologous genes from other organisms, which had not
been annotated in existing alternative splicing databases
(15). This prompted us to develop an automated method
to mine EST and mRNA transcript alignments to genomic
sequence with the goal of identifying all possible alterna-
tive splicing combinations, whether coding or non-coding,
in a given gene locus. This work throws the spotlight on
the potential functional importance of intron retention
concomitant with the expression of short RNAs, and
on unannotated exons in human with low sequence
conservation.
MATERIALS AND METHODS
Data sources
Tables of BLAT alignments (16) of RefSeq (17), mRNAs
and spliced ESTs to a genome assembly were obtained
from the UCSC Genome Browser http://genome.ucsc
.edu/ (18,19). BLAT alignments of spliced ESTs taken
from the UCSC Genome Browser have a minimum of
96% base identity with the genomic sequence and only
carry introns smaller than 750000 bases; in addition,
such spliced ESTs have at least one intron of minimum
length 32 bases with a GT...AG consensus splice site. The
chromosome sequences were downloaded from the UCSC
Genome Browser for the human genome assembly, Homo
sapiens (20) and mouse genome assembly, Mus musculus
(21). Human ESTs used in this analysis originate from
libraries generated from a variety of tissue sources
(45% from normal tissue, 26% from tumor tissue or cell
lines, 2% from disease tissue and 27% with no tissue
annotation).
Data processing
The genomic region of a gene was determined as that to
which all RefSeq BLAT alignments associated with a
given Entrez GeneID (22) mapped, extended to any
mRNA or spliced EST with at least one spliced junction
in common with the RefSeq alignments. For unspliced
RefSeq genes, all mRNA and spliced EST alignments
falling within the boundaries of the gene region were con-
sidered. BLAT alignments of transcripts consist of a series
of aligned blocks separated by gaps of genomic sequence.
Several steps were taken to ﬁlter out data not considered
suﬃciently robust to permit extraction of information on
alternative splicing. To establish the minimum intron size,
we looked for the smallest RefSeq intron carrying the
splice site consensus sequences GT...AG, GC...AG or
AT...AC and found it to be 30nt. Based on this, a
minimum intron size of 30nt was postulated and, as a
result, any two adjacent blocks separated by gaps
smaller than 30nt were not considered reliable introns
and were joined into a single block. These small gaps
can be due to short repeats of variable length in the
genomic sequence and the transcript or to short stretches
of the transcript which the BLAT program did not
succeed in aligning often due to single nucleotide poly-
morphisms; their occurrence was mostly seen in 50 and 30
untranslated regions. Blocks in the BLAT alignment of a
transcript mRNA or EST are potential exons. The
smallest exon, which we have detected in RefSeq
annotated human genes, is 6nt (in the RELN gene), but
we found that it is not mapped correctly to the genome
assembly in UCSC BLAT alignments. In total, eight
blocks with 7nt were found in RefSeq genes but of these
only one mapped with consensus splice sites in UCSC
BLAT alignments. In total, nine blocks with 8nt were
found in RefSeq genes and, of these, seven mapped with
consensus splice sites. There are more than 50 blocks of
9nt in RefSeq genes and, with few exceptions, these map
with consensus splice sites in UCSC BLAT alignments.
A 9-nt block was therefore chosen as a reliable lower
threshold to impose on the size of blocks. The ﬁrst two
and last two nucleotides of each remaining gap in the
alignment were then analyzed for splice site consensus se-
quences GT...AG, GC...AG, or AT...AC in the case of
an mRNA source; and GT...AG or GC...AG in the case
of an EST source. Where a splice site consensus did not
exist, or a block was smaller than 9nt, an alignment was
cut into fragments at the non-consensus junction or on
either side of the small block, respectively. Given that
RefSeq sequences are constantly reviewed and are here
used as reference sequences for a given gene, the
program overrides this ﬁltering procedure for RefSeq
alignments and all of these are accepted regardless of the
consensus sequence at the splice junction and the size of
the aligned blocks. For the above set of ﬁltered data, the
start and end of each alignment were corrected to the
nearest known spliced junction or, for the terminal
regions, to the longest corresponding block, using a set
of rules described in the Supplementary Data. The result-
ing blocks were considered to correspond to exons and the
intervening gaps to introns and each sequence segment
was numbered and assigned a type. Thus, only a single
EST or mRNA is required to support a new exon,
provided that the aligned sequence has 96% identity to
the genome assembly, that it contains at least one intron
with consensus splice sites and has at least one splice site in
common with a RefSeq annotated exon. No special re-
quirement was imposed on ﬁrst or last exons other than
that these must have at least 9nt (the minimum block size
required) and splice site consensus sequences. If a gap
>30nt between the ﬁrst exon and the next exon does
not have consensus splice sites the ﬁrst exon is excluded,
idem for terminal exons. The data on alternative splicing
were generated in such a way as to allow visualization of
all possible exons, within the context of a whole
protein-coding gene. Alternative splicing patterns were
determined as the longest pattern containing a distinct
set of alternatively spliced exons. In this manner, informa-
tion contained in a set of several thousand ESTs could be
condensed by several orders of magnitude.
The collection of unannotated exons used in this study
consists of the exons which are not annotated in RefSeq
Nucleic Acids Research, 2010,Vol.38, No. 14 4741transcripts and excludes 30 and 50 extensions of exons. The
complete set of data resulting from this treatment was
integrated into a public interactive database called
ExonMine freely available at: http://www.imm.fm.ul
.pt/exonmine/.
Generation of data from random sets of ESTs
To assess the eﬀect of the number of ESTs on estimates of
levels of alternative splicing, the procedure discussed
above was used with random sets of ESTs at intervals of
0.5 million ESTs, ranging from 0.5 to 2 million ESTs for
mouse and 0.5 to 4 million ESTs for human. For each
point, two random sets were generated and these displayed
a variation of <0.1% in the percent of genes with more
than one splicing pattern, <0.1 in the average number of
exons per gene and <0.1 in the average number of splicing
patterns per gene.
Analysis of poly-A signals in terminal exons and TSS in
ﬁrst exons
Since the data generated relies largely on fragments of
transcripts, we assessed the likelihood of our terminal
exons (exons with no 50splice site) being true terminal
exons by the presence of the poly-A signal AATAAA
and single nucleotide variants of this signal (23).
Similarly, the likelihood of ﬁrst exons being true ﬁrst
exons (exons with no 30 splice site) was estimated by the
presence of transcription start sites (TSSs): to do this, the
database of TSSs DBTSS, Version 7.0 15 Sep.2009, (24)
was matched against ﬁrst exons, including the region
200nt upstream.
Tiling array data
Tiling array data covering the non-repetitive portion of
the human genome (25) were obtained from NCBI Geo
Dataset GSE7576. These data related to the 2004 human
genome assembly sequence (NCBI Build 35, hg17); there-
fore, the genomic coordinates of the tiling array probe
signals were lifted to the March 2006 human genome
assembly sequence (NCBI Build 36.1, hg18) using
BLAT. Data from the ExonMine August 2008 update
on human genome assembly hg18 were matched to tiling
array probe signal and to short and long transcribed frag-
ments. Short transcribed fragments in the tiling array data
range in size from 22 to 200nt and were detected, in that
study, in HeLa and HepG2 cell lines, both from the+and
–strand, across the whole nonrepetitive fraction of the
human genome.
Analysis of repetitive elements
The presence of repetitive elements in unannotated exons
was determined by pairwise alignment against RepBase
version 13.10 (26) using blastn (27). An exon was con-
sidered to contain a repetitive element if the alignment
had a minimum of 80% identity over a minimum query
aligned length of 50nt.
P-value calculation for short RNAs associated with
retained introns
To show that short RNAs are more strongly associated
with retained introns than with all introns within the size
range of retained introns (population 1) or within the
population of all introns (population 2), we calculated
the statistical signiﬁcance of our result. As we are
dealing with a yes/no issue we used a binomial distribu-
tion, which is fully deﬁned by one parameter, P, in this
instance, the probability of ﬁnding introns carrying
short RNAs: P=(number of introns carrying short
RNAs in a population)/(total number of introns in
that population). To estimate this parameter, we assume
the ‘largest group’ to be representative for the population.
For population 1, P=31325/126292=0.2480; and for
population 2, P=64844/205975=0.3148. To show that
the set of retained introns conﬁrmed by 50% coverage of
tiling array transcribed fragments in the cytoplasm
(50CytoTF set) is not a random sample taken from this
large group we calculate the P value. The mean of a
binomial distribution is M=N P and the standard de-
viation is s=ˇ (M (1–P)) where N=7381 is the number
of introns in the 50CytoTF set. For the 50CytoTF set this
results in: M=7381 0.2480=1830.76 and s=37 for
population 1; and M=7381 0.3148=2323.65 and
s=40 for population 2. To calculate the P-value, we use
the fact that a binomial distribution for N=7381 can
practically completely be represented by a normal distri-
bution. This allows us to convert the 50CytoTF data to a
standard normal distribution which has a mean of 0 and a
standard deviation of 1; this standard normal distribution
in its turn allows the use of standard tables, to derive the
P-value. The formula for this conversion is z=(x–M)/s
where x is the observed number of introns carrying
short RNAs in the 50CytoTF set. For population 1
z=(2663–1830.76)/37=22.43 and for population 2
z=(2663–2323.65)/40=8.50. Using the above-
mentioned tables, we derived a P-value<0.0001.
According to conventional criteria this means that the
number of short RNAs observed in the 50CytoTF set is
extremely statistically signiﬁcant.
GC content in introns
GC content was determined in three sets of introns of 2500
small introns, small introns being smaller than 1029nt, as
previously deﬁned (28). Set Rs: retained introns that have
at least 50% of their surface covered by tiling array
transcribed fragments in the cytoplasm and also
matching short transcribed fragments (25); set Rns:
small retained introns that have at least 50% of their
surface covered by tiling array transcribed fragments
(25) in the cytoplasm but do not match short transcribed
fragments; and set NR: small non-retained introns. We
imposed the same number of introns and size distribution
for sets Rns and NR as was observed for set Rs: this was
done by random selection of the same number of introns
in each quartile and outliers as that observed in set Rs. To
test whether the diﬀerence in the mean GC content in two
sets of introns is large enough that it is most likely that the
4742 Nucleic Acids Research, 2010,Vol.38, No. 14means come from two diﬀerent populations, the
two-tailed P-value for a t-statistic was calculated for
unequal variance.
Search for known small RNAs
To support the possibility of retained introns being
involved in production of small RNAs, we searched
UCSC table browser (19) data based on the miRBase
(Release 13.0, March 2009) Sequence Database (29) for
precursor of microRNAs; snoRNABase (version 3) for
C/D and H/ACA box small nucleolar RNAs and small
Cajal body-speciﬁc RNAs (scaRNAs) data from the
Laboratoire de Biologie Mole ´ culaire Eucaryote (30).
Sequence conservation analysis
Sequence conservation analysis of human unannotated
exons and retained introns was performed using
discontiguous megablast (27,31) across eight vertebrate
species: chimp (Pan troglodytes, taxid:9598) and rhesus
(Macaca mulata, taxid:9544) genomes were used to repre-
sent nonhuman primates; mouse (Mus musculus,
taxid:10090) and rat (Rattus norvegicus, taxid:10116)
genomes were used to represent non-primate
supraprimates; dog (Canis familiaris, taxid:9615), horse
(Equus caballus, taxid:9796) and cow (Bos taurus,
taxid:9913) genomes were used to represent laurasiatheria,
another large group of placental mammals; chicken
(Gallus gallus, taxid:9031) was used to represent a
nonmammalian vertebrate genome. Discontiguous
megablast is a version of Mega BLAST designed speciﬁc-
ally for comparison of diverged sequences, especially se-
quences from diﬀerent organisms. The parameters, which
we applied for this conservation analysis, are those recom-
mended by the authors for cross-species analysis. The
analysis was performed on chromosomes using the follow-
ing parameters: a word size of 11; reward/penalty scoring
parameters for matching and mismatching bases of 1/–1;
associated gap existence penalty of 5; gap extension
penalty of 2; a ﬁlter was applied to mask low complexity
regions for the lookup table only; human speciﬁc repeats
were ﬁltered; and, ﬁnally, a discontiguous maximal
template type with length 16 was used. A sequence was
considered conserved if alignments displayed more than
70% identity over at least 80% query coverage with
bitscores >50 and E (expect) values <0.05.
RESULTS
ExonMine detects a higher number of exons and
alternatively spliced genes
Alternative splicing data generated using the method
described above for the complete human genome
resulted in the detection of 256605 core exons (i.e.
excluding exon extensions) covering 18727 genes (haplo-
types excluded) (Table 1). The position of these exons in
transcripts is 16% ﬁrst (40418 exons), 73% internal
(186837 exons) and 11% terminal (28292 exons). The
identiﬁed exons are involved in a total of 199045
distinct splicing patterns, giving an average of 10.6
splicing patterns per gene. All exons and splicing
patterns can be tracked to the original set of mRNA
and EST input data through ﬁxed numbering of exons
and introns in relation to a reference RefSeq sequence.
The complete data set can be visualized online on the
ExonMine database at: http://www.imm.fm.ul.pt/
exonmine/.
Table 1 compares ExonMine data for human and
mouse with data from two recently published alternative
splicing databases (32,33). For both human and mouse,
ExonMine detects a higher percentage of alternatively
spliced genes, 88% compared to 78% in fastDB and
53% in ASAPII for human; and 79% compared to 54%
in fastDB and 53% in ASAPII for mouse. Most striking is
the fact that ExonMine data detects a 27% increase in the
average number of exons detected per gene in human (14
exons per gene) compared to the highest detected by
fastDB (11 exons per gene). This is most likely due to
diﬀerences imposed on the selection of transcripts. For
example, in fastDB transcripts are initially selected by
blasting each exon, deﬁned by EnsEMBL (34), against
mRNA and EST alignments to the genome, whereas
ExonMine relied on BLAT alignments that require a tran-
script to have only one splice site in common with RefSeq
transcripts. Global percent identity of alignment of tran-
scripts in fastDB is 98% versus 96% in ExonMine. In
fastDB, at least 95% of the transcript has to be aligned,
it must cover 10% of the genomic region, and the ratio of
exon and intron lengths in a given transcript cannot
exceed three times the average ratio of all deﬁned exon
and intron lengths; whereas ExonMine cuts alignments
into fragments at non-consensus junctions and on either
side of exons smaller than nine nucleotides and recovers
any spliced fragments. As a result of the diﬀerences in data
selection criteria, ExonMine succeeds in capturing more
Table 1. Comparison of our results with other databases
Database Human Mouse
No.
genes
Genes with
AS (%)
No. exons
a Average no.
exons per gene
No.
genes
Genes with
AS (%)
No. exons
a Average no.
exons per gene
ExonMine 18727 88 256605 14 19110 79 215343 II
fastDB 18008 78 201245 11 13913 54 157920 II
ASAP II 22220 53 129981 6 16404 53 105260 6
Alternative splicing data generated in this analysis (here referred to as ExonMine data) compared to FastDB (32), ASAP II (33).
aFor our data this count includes only the core part of an exon, i.e. excluding exon extensions.
Nucleic Acids Research, 2010,Vol.38, No. 14 4743than three times the number of ESTs and mRNAs than
fastDB. ExonMine also clustered the great majority of
human spliced ESTs (97%), which suggests a near
complete coverage of spliced genes by human RefSeq
transcripts.
The complexity of alternative splicing is higher in human
than in mouse
The evaluation of levels of alternative splicing based on
ESTs in limited sets of EST data has been shown to be
dependent on the number of ESTs available (35).
However, there is an element of redundancy in EST
coverage when large quantities of spliced ESTs are avail-
able, as in the case of human (3.9 million) and mouse
(1.9 million) where the number of ESTs is an order of
magnitude above that of the number of exons. In our
analysis, for human and mouse, 78% and 79% of the
total number of exons respectively are covered by two or
more ESTs. This level of coverage allows us to begin to
compare the levels of alternative splicing detected in these
two organisms.
To assess how the number of ESTs can aﬀect the
determined level of alternative splicing we generated our
results from random sets of ESTs at intervals of 0.5
million: ranging from 0.5 to 2 million in mouse and 0.5
to 4 million in human (Figure 1). For the percentage of
genes with alternative splicing (Figure 1A), although we
see an increase from 81.7% (estimate with 0.5 million
ESTs) to 88.2% (estimate with 4 million ESTs) for
human, at the latter point we appear to be reaching a
threshold. The same can be said for the number of
exons per gene (Figure 1B), which has reached 13.6 in
human and 11.2 in mouse with the available data.
However, when we estimate the number of splicing
patterns per gene no threshold appears to have been
reached yet (Figure 1C). This may either be due to
spurious alternative splicing obtained from in vitro ma-
nipulations or, indeed, reﬂect a real increase in complexity
of alternative splicing due to the increased combinatorial
possibilities resulting from a greater number of exons per
gene in human. On the whole, the results shown in
Figure 1 suggest that the level of alternative splicing in
mouse is consistently below that of human.
In relation to RefSeq, we detect seven times more
splicing patterns in human and ﬁve times more in
mouse. Mining for alternatively spliced exons in human
mRNA and EST data resulted in the identiﬁcation of
48942 unannotated exons >25nt, spliced to exons in
annotated RefSeq transcripts, 60% of which occur in
normal tissues and only 16% in cancerous tissues. Out
of a total of 18727 genes considered in this analysis,
13497 (72% of genes) carry unannotated exons, 97.7%
of which appear in completely spliced transcripts. Sixty
percent of the unannotated exons are supported by at
least one mRNA or two ESTs.
Both in human and mouse, the majority of unannotated
exons are ﬁrst exons, 45% in human (Figure 2B) and 52%
in mouse, this contrasts with the distribution of ﬁrst,
internal and terminal exons found in the whole set of
annotated exons where 16% of exons are ﬁrst exons
(Figure 2A). In our data, ﬁrst exons are those for which
no 30 splice site was detected and terminal exons are those
for which no 50 splice site was detected. Since our data rely
heavily on ESTs, which are fragments of transcripts, we
estimated the likelihood of ﬁrst exons being true ﬁrst
exons by matching these data with the latest version of
the database of transcription start sites (DBTSS) (24). We
found that 63% (Figure 2C) of new ﬁrst exons match TSS
in normal adult and fetal tissue (75% when cell lines are
included). In known ﬁrst exons we found matches for TSS
Figure 1. Eﬀect of number of ESTs on estimates of levels of alternative
splicing. Data generated from random sets of ESTs at intervals of 0.5
million ESTs, ranging from 0.5 to 2 million for mouse and 0.5 to 4
million for human. (A) Percent of genes with more than one splicing
pattern. (B) Average number of exons per gene. (C) Average number of
splicing patterns per gene.
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lines were included). Although TSSs were also found in
21% of known internal exons, for normal adult and fetal
tissue, this result suggests that only 25% of new ﬁrst exons
found are internal, derived from fragments of transcripts,
rather than true ﬁrst exons.
To assess the likelihood of new terminal exons being
true terminal exons, we determined the number of
terminal exons carrying the poly-A signal AATAAA and
1-nt variants of that signal (23) (Figure 2D). By true
terminal exon we mean that it is the last exon to be
spliced (i.e. no 50 splice site was detected throughout the
data) and it contains a polyadenylation signal. We ﬁnd
that only 30% of unannotated terminal exons contain
the consensus poly-A signal (61% when one nucleotide
variants of the poly-A signal are included) compared to
78% in known terminal exons (97% for variants of the
poly-A signal). By contrast, in ﬁrst exons and internal
exons, the poly-A signal and its variants are only found
in 4% of cases for the consensus AATAAA to a maximum
of 12% for the AAGAAA variant. This result suggests
that at least 39% of the terminal exons found might in
fact be internal exons for which the complete transcript is
still undetermined.
Overall, one-third of unannotated ﬁrst exons and
internal exons in human and mouse are in frame with
downstream known exons and are thus expected to con-
tribute putative coding sequence.
Novel exons are validated by tiling array expression data
Comparison of unannotated exons identiﬁed by our
analysis with expression data from tiling arrays for
eight cell lines (25) shows that 37% of the unannotated
exons are not covered by suﬃcient tiling array probes
to be detected as transcribed fragments, notwithstanding,
44% are represented in transcribed fragments in the tiling
array data, with 35% expressed in the cytoplasm.
In light of recent reports suggesting that repetitive
elements, such as the Alu element, play an important
role in the evolution of alternative splicing in primates
(36,37), we searched for the presence of vertebrate repeat
elements, deposited in RepBase 13.10 (26), in unannotated
exons using Blastn. This analysis revealed that 24% of
unannotated exons align with repeats. By far the most
abundant repetitive element found was the primate
speciﬁc Alu element found in 12% of unannotated exons
( 6000 exons). Since the tiling array data cover only the
nonrepetitive fraction of the genome, the latter are
expected to escape detection by array analysis.
To illustrate this analysis, an example of tiling array
data for gene ZRSR2 is presented in Figure 3, in which
four unannotated exons were found. The unannotated
exon 1A presents a signal comparable to that of known
exons in all eight cell lines, whereas exons 2A, 3A and 3B
are not covered by probes. The latter three exons are an
example of exonization of tandem insertions of the
primate speciﬁc Alu repeat element (38). On the other
hand, tiling array data also indicate that exon 1A coin-
cides with short transcribed RNA fragments ranging from
22 to 200nt (25), suggesting a non-protein-coding function
for this particular exon. However, we did not ﬁnd a higher
number of short transcribed fragments from the tiling
arrays (putative short RNAs) associated with
unannotated exons than with annotated exons (Table 2):
whereas 64% of annotated ﬁrst exons match short
transcribed fragments from the tiling arrays, only 37%
on unannotated exons do so. On the whole, it appears
that ﬁrst and terminal exons, but in particular ﬁrst
exons, are more often associated with short transcribed
fragments than internal exons, suggesting a stronger regu-
latory role associated with short RNAs for ﬁrst and
terminal exons than for internal exons, the latter being
naturally expected to perform mainly a protein coding
function.
A large fraction of isoforms contain retained introns
Analysis of spliced transcripts carrying intron retentions
revealed 16288 retained introns in human, belonging to
7708 genes (41% of genes). Only 3% of these intron re-
tentions are annotated in RefSeq transcripts. Among the
RefSeq annotated retained introns, 37% do not alter the
reading frame. In our set of 16288 retained introns, 33%
Figure 2. Relative amounts of ﬁrst, internal and terminal exons. (A)
Relative amounts of ﬁrst, internal and terminal exons in known
(RefSeq annotated) exons. (B) Relative amounts of ﬁrst, internal and
terminal new (unannotated) exons. (C) Percent of ﬁrst known and new
exons containing transcription start sites (TSSs) within the exons or
200nt upstream [DBTSS (24), Version: 7.0, 15 September 2009). (D)
Percent of terminal exons containing the poly-A signal or 1-nt variants
of the consensus AATAAA sequence (23). First exons are those for
which no 30 splice site was detected. Terminal exons are those for which
no 50 splice site was detected. Internal exons have both a 30 splice site
and 50 splice site. This analysis includes only exons with minimum 25nt
and excludes chimeric transcript products.
Nucleic Acids Research, 2010,Vol.38, No. 14 4745do not alter the reading frame. This corresponds to what
would be expected in a random-sized set of introns. The
human data contain approximately twice the amount of
splicing patterns with intron retentions as the mouse data.
To investigate the biological signiﬁcance of transcripts
with retained introns in human, we analyzed the expres-
sion data obtained from tiling arrays covering the whole
nonrepetitive fraction of the human genome for eight cell
lines (25). Of the 16288 introns detected by our analysis,
7.5% were covered by <11 tiling array probes and there-
fore could not be analyzed. In contrast, 70% of the
retained introns were covered by at least 50nt of
transcribed fragments isolated from either the nucleus or
the cytoplasm and 45% were detected as having at least
50% of their surface covered by transcribed fragments
isolated from the cytoplasm. This contrasts with 14% ex-
pression in cytoplasmic transcribed fragments detected in
tiling arrays for all other non-retained (spliced) introns
within the same size range (109817 introns). This result
prompted us to further characterize these introns that ap-
parently are unspliced in the nucleus and are exported to
the cytoplasm (referred to in this text as the 50CytoTF
retained intron set).
Retained introns are short and a subset, associated with
expression of small RNAs, has a high GC content
Introns come in a very wide range of sizes, from as small
as 30nt, the smallest intron size detected in RefSeq tran-
scripts, to as large as several hundred kilobases, with the
majority of introns (71%) being longer than 500nt. An
analysis of the size range of the 50CytoTF set of
retained introns shows that the vast majority (87%) are
shorter than 500nt. In most of these cases (78%), the
transcripts contain a single retained intron, whereas in
23% of the cases there are transcripts with more than
one intron retained. As many functional short RNAs are
transcribed from intronic regions of protein coding genes,
we analyzed the distribution of short RNAs associated
with three sets of introns: all non-retained introns;
retained introns that are detected in the cytoplasm
(50CytoTF set); and retained introns not conﬁrmed by
tiling array data (Figure 4). According to the tiling array
data, we found that short RNAs are generally associated
with introns of all sizes (Figure 4A). However, within the
size range of retained introns, we found that retained
introns conﬁrmed by tiling array data (50CytoTF set)
have a higher correlation with short RNAs than
non-retained introns (Figure 4B), P-value <0.0001.
Recently published deep sequencing data (8) were also
analyzed for the presence of retained introns. In the pub-
lished data, we found 105 retained introns ranging in size
from 69 to 327nt (Supplementary Data). With one excep-
tion, all of these intron retentions occur between RefSeq
annotated exons; however, the intron retentions
Figure 3. Tiling array data for fragment of gene ZRSR2. Coordinates for signal and transcribed fragments of tiling array data [Geo Accession
GSE7576 (25)] of all eight cell lines used in that study for human genome assembly hg17 were lifted to assembly hg18 and matched to ExonMine
data (August 2008 update). The graph represents data for the 50-end of gene ZRSR2. Nuclear signal (yellow) and cytoplasmic signal (red) shown.
Exon positions from our ExonMine data (blue) and transcribed fragments from tiling array data are represented superimposed on the negative axis:
cytoplasmic (red), nuclear (yellow), short RNA top strand (green) and short RNA bottom strand (cyan). The ﬁgure shows that probe coverage on
the tiling array is absent or too low for Alu containing unannotated exons 2A, 3A and 3B. For unannotated exon 1A, however, there is a clear
nuclear and cytoplasmic signal as well as correspondence to short RNA transcribed fragments in that region. The ﬁgure also shows expression which
is not detected in ExonMine, including: on the 50-end of the intron downstream of exon 2; several transcribed fragments between exons 2 and 2A
likely to correspond to a gene on the opposite strand for which there is only EST evidence (AA284226); and a transcribed fragment just upstream of
exon 3 with a low signal.
Table 2. Exons matching short RNAs
ExonType Known exons matching
short transfrag (%)
New exons matching
short transfrag (%)
fe 64 37
e1 1 1 2
te 39 19
This data relates to exons conﬁrmed by a minimum of 25 nts expressed
in tiling arrays (25) both in the cytoplasm and in short transcribed
fragments.
4746 Nucleic Acids Research, 2010,Vol.38, No. 14themselves are not annotated by RefSeq. Our analysis, on
the other hand, detects 24 of these intron retentions. In
92% of the cases detected by deep sequencing, the reten-
tion of the intron does not disrupt the reading frame.
Comparison of intron retention events detected by deep
sequencing with the tiling array data shows that 72 of
these introns (68%) have 50% coverage by cytoplasmic
transcribed fragments and 34 (33%) are associated with
short transcribed fragments (short RNAs).
The mean GC content of human introns in general has
been reported as 43.51%, small introns (smaller than
1029nt), having a higher GC content (28). We undertook
an analysis of GC content in three sets of introns smaller
than 1029nt: small retained introns (from 50CytoTF set)
matching short transcribed RNAs (set Rs); small retained
introns (from 50CytoTF set) not matching short
transcribed fragments (set Rns); and small introns not
found to be retained (set NR). In addition to the size re-
striction, we required that the sets Rns and NR have the
same size distribution as set Rs, by random selection of the
same number of introns in each quartile and outliers as
were observed in set Rs (Figure 5A). The GC content of
each set was then measured and we found set Rs to have
63% GC content compared to 50% and 49% in sets Rns
and NR, respectively (Figure 5B). We obtained a P-value
= 1.9e-26 for comparing the mean GC content of sets
Figure 4. Distribution of intron size range and presence of short RNAs. (A) The plot represents the distribution of size range of three sets of introns.
AIt: total non-retained introns (222721 introns); RTt: total retained introns with 50% of surface matching tiling array (25) transcribed fragments in
the cytoplasm (50CytoTF set, 7381 introns); and RIt: total retained introns not conﬁrmed by tiling array data (8907 introns); and their corresponding
subsets matching short transcribed fragments detected in tiling arrays (AIs: 60090 introns, RTs: 2663 introns and RIs: 1908 introns). Tiling array
data for short RNAs (short transcribed fragments, 22–200nt) was taken from (25). (B) Percentage of total introns in each set containing short RNAs
plotted against Log10 of intron length. % AIs/AIt: non-retained introns; % RTs/RTt: 50CytoTF retained intron; % RIs/RIt: retained introns not
detected in tiling array data. Within the size range of retained introns, this plot reveals that the 50CytoTF set of introns carries more short RNAs
than non-retained introns. The calculated two tailed P-value for the diﬀerence observed, is <0.0001 (see ‘Materials and Methods’ section).
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P-value that is so very small, in the former result, means
that, with regard to GC content, it is close to certainty that
Rs introns form a distinct set. As GC-rich regions can form
more stable RNA secondary structures, this enrichment
could reﬂect such a tendency and be implicated in involve-
ment of splicing regulation in small RNA biogenesis.
Next, we compared the frequency of occurrence of
each nucleotide at the splice sites using WebLogo (39)
(Figure 6), for the three above sets, Rs, Rns and NR
and for all introns. At the 50 splice site, the most promin-
ent feature in small introns (Figure 6A, C and D) is a
tendency for higher guanine content rather than a prefer-
ence for uridines as is observed in all introns (Figure 6B);
and in set Rs (Figure 6A) the higher GC content at this
splice site is even more marked than for small
non-retained introns (NR) and small retained introns
not matching short transcribed fragments (Rns). The
strength of the Py-tract at the 30 splice site can be
assessed in terms of its uridine content: at the 30 splice
site, set Rs appears to have a much weaker Py-tract
(Figure 6A) than the other three sets. Set Rns of
retained introns also appears to have a shorter and
weaker Py-tract than non-retained small introns (set
NR) with long introns showing the strongest Py-tract.
The weakness of the Py-tract in retained introns (sets Rs
and Rns) is likely to be implicated in regulation of alter-
native splicing requiring additional splicing factors (40).
Given the possibility of retained introns being involved
in production of small RNAs we searched the miRBase
Sequence Database for precursors of microRNAs, and
for C/D and H/ACA box small nucleolar RNAs
(snoRNAs) and small Cajal body-speciﬁc RNAs
(scaRNAs) in snoRNABase data from the Laboratoire
de Biologie Mole ´ culaire Eucaryote. In the Rs set of
retained introns we found 1 known microRNA, and 11
known C/D box and 7 H/ACA box snoRNAs
(Supplementary Data). By contrast, in the Rns set of
retained introns, no known small RNAs were found and
only one known C/D box snoRNA was found in
non-retained introns (set NR).
Figure 6. Frequency of nucleotide occurrence at splice sites. Logos representing the frequency of occurrence of nucleotides at each position at the
50splice site (3nt upstream and 20nt downstream) and at the 30splice site (30nt upstream and 3nt downstream) were produced using WebLogo (39).
Uridines are represented by Ts. (A) Set Rs, 2500 small retained introns matching short RNAs, as described in Figure 5. (B) Random set of 2500
introns of all sizes. (C) Set Rns, 2500 small retained introns not matching short RNAs, as described in Figure 5. (D) Set NR, 2500 small non-retained
introns, as described in Figure 5.
Figure 5. GC-content in retained and non-retained introns. GC
content in three sets of 2500 introns each. Set Rs: small retained
introns validated by tiling array data (25) in the cytoplasm and also
matching short transcribed fragments; set Rns: small retained introns
not matching short transcribed fragments; and set NR: small
non-retained introns. Small introns are <1029nt as deﬁned in (28).
(A) Boxplots of all three sets Rs, Rns and NR. Introns in sets Rns
and NR are composed of a random selection of the same number of
introns in each quartile and outliers as in set Rs: lower hinge=30,
extreme lower whisker=102, median=185, upper hinge=337,
extreme upper whisker=687, lower extreme of notch=177.6, upper
extreme of notch=192.4, 153 outliers. (B) Percent GC content in each
of the three sets Rs, Rns and NR.
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Conservation analysis of unannotated exons and retained
introns was performed using discontiguous megablast for
eight species: nonhuman primates were represented by
chimp and rhesus; nonprimate supraprimates were repre-
sented by the rodents mouse and rat; laurasiatheria,
another large group of placental mammals, was repre-
sented by horse, dog and cow; and a nonmammalian
vertebrate was represented by chicken. To evaluate con-
servation, we counted the number of exons or introns
above the threshold of 70% identity over at least 80%
of the sequence (Figure 7). The threshold of conservation
imposed would be expected to detect sequences with
protein coding potential. However, for chimp and
rhesus, the high level of overall sequence similarity to
the human genome, 98–99% in chimp (41) and 93% in
rhesus (42), precludes the use of sequence conservation to
postulate on the protein coding potential of a sequence.
Conservation in introns was analyzed for sets Rs and
Rns of retained introns, and in the set NR of non-retained
introns, all with the same size distribution as set Rs
(Figure 7A). For retained introns not matching short
transcribed fragments (Rns) we observed, in all placental
organisms, a higher number of conserved introns than for
retained introns matching short transcribed fragments
(Rs). Non-retained introns within the same size range
(set NR), on the other hand contain a lower (in the case
of rodents, dog and cow) or equivalent (in the case of
horse, rhesus and chimp) number of conserved introns
as set Rs. This supports the non-coding hypothesis for
set Rs setting it apart from set Rns. The number of
introns conserved in chicken was negligible.
To evaluate conservation in exons, the analysis was per-
formed on 9371 unannotated exons with expression
validated by a minimum of 50% sequence coverage by
tiling array (25) transcribed fragments detected in the
cytoplasm (Figure 7B). Exons containing repetitive
elements were excluded. This analysis was done alongside
a random set of 2500 annotated exons. In all placental
mammals, we found a signiﬁcant number of exons
conserved, 18% in rodents, 28% in dog and cow and
36% in horse, but only 4% in chicken.
One thing that stands out in the conservation analysis of
both introns and exons is that a greater number of se-
quences appear to be conserved in horse, dog and cow
than in rodents, which are generally accepted as being
more closely related to primates.
DISCUSSION
Alternative splicing is often proposed to account for the
diﬀerential complexity of organisms with similar number
of genes and is considered an important driver of the evo-
lution of phenotypic complexity in mammals (43). This
assumption implies that more complex organisms are
expected to have more alternative splicing. However,
previous studies addressing this view have provided con-
ﬂicting results (35,44–47). However, assessing the
complete inventory of gene and mRNA isoform expres-
sion in diﬀerent cell types of diﬀerent organisms has been
hampered by substantial technical challenges. Initial
studies, using expressed sequence tags, have yielded rela-
tively low estimates of alternative splicing, in part because
EST data contain various sources of limitations—for
example, EST coverage is typically biased toward the 30-
and 50-ends of transcripts, EST quality and methods by
which they were produced are very variable and, in
general, there are insuﬃcient numbers of sequenced tran-
scripts covering diﬀerent cell types in multiple species.
More recently, microarray analyses achieved a more
comprehensive coverage of the human transcriptome
(6,7), but this approach is still constrained by relying on
hybridization to speciﬁc probe sets. The most recently
developed high-throughput sequencing technologies
have the potential to circumvent these limitations and
several recent studies have used mRNA-Seq data to
survey alternative splicing in human and mouse transcrip-
tomes (8–10,48–50). An important corollary of these
studies was the identiﬁcation of new exons and splice junc-
tions not previously included in transcript databases.
Figure 7. Conservation of unannotated exons and retained introns.
Conservation estimated using discontiguous megablast (see ‘Materials
and Methods’ section) against eight species: chimp, rhesus, mouse, rat,
dog, horse, cow and chicken. The bars represent the percentage of
exons or introns with a minimum of 70% sequence conservation over
a minimum of 80% sequence coverage. (A) Conservation in intron sets
Rs, Rns and NR as described in Figure 5, with the same size distribu-
tion. (B) Conservation of known (RefSeq annotated) and new
(unannotated). Known exon set consists of a selection of 2500
random exons. Unannotated exons consist of the set of 9371 previously
unannotated exons validated by more than 50% coverage of tiling
array transcribed fragments in the cytoplasm. The error associated
with the use of random sets of 2500 sequences was estimated at less
than±1%.
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appear in current alternative splicing databases due to
constraints imposed in the selection of transcripts. We
therefore developed a less-constrained method and,
having made the complete data set available, online at
http://www.imm.fm.ul.pt/exonmine/, we proceeded to
use this novel resource to investigate alternative splicing
in the human and mouse transcriptomes.
Using our data mining method, we detected a higher
rate of alternative splicing in the human compared to
the mouse transcriptome. Consistent with our results,
Kim et al. (35) reported that humans have more alterna-
tively spliced genes and alternative exons than mice, and
conﬁrmed that this higher level of alternative splicing is
not a result of ESTs derived from cancer cells that could
increase the amount of aberrant splicing. However, given
the limitations of EST data, future deep-sequencing
analyses of multiple transcriptomes is likely to provide a
clearer picture of the relationship between alternative
splicing and organismal complexity.
In this study, extensive mining of mRNA and EST data
resulted in the identiﬁcation of previously unannotated
exons in 72% of human genes. In the vast majority of
cases (97.7%), the novel exons were detected in completely
spliced transcripts. The results further reveal a high pro-
portion of novel ﬁrst exons, suggesting that alternative
initial exons in the human transcriptome might be more
frequent than previously thought. We also found overall a
much greater number of ﬁrst and terminal exons
associated with short RNAs, which could reﬂect position-
al regulation of gene transcription at the start and end of a
gene, leaving internal exons to perform mainly a protein
coding function.
We found that 24% of unannotated exons aligned with
repeat elements, suggesting that the majority probably
evolved by a mechanism distinct from exonization of fre-
quently transposed elements such as the Alu element,
which was the most abundant element found in  6000
(12%) unannotated exons. From a total of 48942
unannotated exons, 44% were validated by tiling array
expression data which covers the nonrepetitive part of
the human genome, with 35% expressed in the cytoplasm,
whereas 37% were not covered by probes in the array.
This analysis of expression data from human tiling
arrays provides a strong validation of unannotated
exons identiﬁed by our data mining method.
A large fraction of unannotated exons appeared to be
ﬁrst exons. Previous strategies for collecting alternative
splicing information have relied to a large extent on
complete transcripts, whereas our approach relies exten-
sively on ESTs, which are fragments of transcripts with a
bias for the 30- and 50-end. First exons, in our data are
simply exons for which no 30 splice site was detected. We
estimated the likelihood of ﬁrst exons being true ﬁrst
exons by matching this data with the latest version of
the database of TSSs DBTSS. This analysis conﬁrmed
that even though the data consist of fragments of tran-
scripts and may be incomplete the majority of ﬁrst exons,
63–75%, harbor TSS and are therefore likely to be true
ﬁrst exons.
Recent genome-wide studies of mammalian promoters
reveal multiple TSSs on a given gene and although some
may be cryptic, many are bona ﬁde diﬀerentially regulated
TSS generating alternative N-termini in protein coding
genes (51). In our procedure for establishing ﬁrst exons,
the cut-Start of each ﬁrst exon in the raw data, with a
common 50ss, is extended upstream to the farthest tran-
script start position in the data, so that our ﬁrst exons
are likely to include several TSSs. All original Genbank
accessions for the data associated with each ﬁrst exon
(or indeed any exon) can be obtained, from our website
(http://www.imm.fm.ul.pt/exonmine/), by inputting the
exon number in ‘Tissue distribution in Gene given the
transcript, junction or exon’ in the ‘Downloads’ section:
if more than one accession is given for a ﬁrst exon, then
the ﬁrst nucleotide of these GenBank transcripts will
either start at the same position as an ExonMine ﬁrst
exon or further downstream within it. This means that
our ﬁrst exons, which match DBTSS, are more likely to
correspond to a single promoter. However, if the RNA
polymerase, originally docking at such a promoter, hypo-
thetically, moved far enough along the gene to start tran-
scription past the ﬁrst 50ss, in that case we would record, in
our data, a new ﬁrst exon or an extension of the ﬁrst exon
with an alternative 50ss. On the other hand, mammalian
promoter architecture is extremely complex and too
diverse to allow accurate computational prediction, in
fact it is thought that most genes may have multiple pro-
moters, each one being associated with multiple TSSs, so
that alternative promoter usage and regulation of TSS
choice is likely to be responsible for generating consider-
able diversity and complexity in the mammalian transcrip-
tome (52). Although it is clear that the biological
determination of individual promoters, the initial
docking sites of the polymerase, and the relation to the
choice of a particular TSS, is a highly complex and unre-
solved problem, sometimes even involving more than one
polymerase (53), this analysis could be approached using
chromatin immunoprecipitation (ChIP) methods for poly-
merases coupled with validation by tissue speciﬁc micro-
array (ChIP–chip) or massively parallel sequencing
methods (ChIP-Seq) (54,55).
The case for terminal exons, which have been extended
downstream to the furthest known cut end in the
GenBank data used, is similar. Our terminal exons
(exons for which only a 30ss has been detected, i.e.
beyond which no more splicing is observed) can contain
several alternative polyadenylation sites. We assessed the
likelihood of terminal exons being true terminal exons
through the presence of the poly-A signal and known
variants of this signal. Here, we obtained a level of
estimated true terminal exons of 30% for the AATAAA
poly-A signal and 61% when known variants of the signal
were considered. Terminal exons where no poly-A signals
were found are likely to be internal exons from incomplete
transcripts. An initial assessment of alternative
polyadenylation site usage within our terminal exons can
be done by looking at the GenBank data supporting a
particular terminal exon.
Several forms of alternative splicing can generate, from
a single gene with multiple introns, a variety of mRNAs
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forms of alternative splicing include: exon skipping, alter-
native 30 splice site usage, alternative 50 splice site usage,
mutually exclusive exons, alternative initial exons, alterna-
tive terminal exons and intron retention (56). To date,
there are only a few cases of intron retention events with
known biological consequences in mammals. These
include the transcription factor Id3 (56), the splicing
factor 9G8 (57), proinsulin (58), ion channels
CACNA1H (59) and KCNMA1 (60), and the Robo3
receptor involved in axon guidance (61). Previous bio-
informatic studies of EST data found evidence for at
least one intron retention event in 5–15% of human
genes (5,62–64), and some of the new predicted variants
containing retained introns have been experimentally
validated (59). However, EST sequence information
alone is generally considered insuﬃcient to identify truly
functional retained-intron isoforms due to possible arti-
facts derived from aberrant cDNA cloning (e.g. cDNAs
produced from incompletely spliced mRNAs or genomic
DNA contaminants).
Using our data mining method, we identiﬁed 16288
intron retention events in 41% of human genes. Of the
16288 retained introns, 7382 (45%) were detected in the
cytoplasm of human cell lines by tiling array analysis (25).
It is therefore unlikely that these transcripts are derived
from unspliced or partially spliced nuclear pre-mRNAs.
Intron retention involves excluding the normal recogni-
tion of a pair of splice sites and bypassing the surveillance
mechanisms that typically prevent export of unspliced
pre-mRNAs to the cytoplasm. Thus, intron retention is
probably regulated by factors involved in both splicing
and mRNA export. Retroviruses (including HIV) are the
best studied systems involving regulated intron retention
and export of unspliced mRNA to the cytoplasm (65).
Unspliced viral RNA overcomes nuclear restriction by
using a cis-acting RNA element known as the constitutive
transport element (CTE), which interacts directly with
the principal export receptor for cellular mRNA. Most
probably, cellular mRNAs with retained introns use
cellular CTE equivalents to be exported to the cytoplasm
(66,67). Retained introns are therefore expected to contain
some common sequence elements that might participate in
the coordinate regulation of splicing and RNA export.
Indeed, both intronic and exonic motifs that aﬀect other
types of alternative splicing have been shown to regulate
intron retention when properly situated (68,69).
Here, we report several lines of evidence supporting the
view that intron retention events in the human transcrip-
tome are speciﬁcally regulated. First, retained introns have
weak Py tracts contrasting with the majority of human
introns which show a signiﬁcant bias for strong Py tracts
(70). Weak Py-tracts have previously been shown to be
implicated in regulation of alternative splicing requiring
additional splicing factors (40). Second, the vast
majority (87%) of retained human introns are shorter
than 500nt contrasting with non-retained introns, which
are typically longer than 500nt. Third, both the weak Py
tract (71) and size of retained human introns are reminis-
cent of plant introns [100–200nt long (71)], and in plants
intron retention is the most prevalent form of alternative
splicing (72–74). Finally, a recent analysis of the human
transcriptome using tiling arrays at 5-nt resolution
revealed the presence of potentially functional short
RNAs ranging in length from 22 to 200nt, many of
which were found in intronic regions (25). Mining these
data sets, we found that transcripts containing retained
introns that are likely precursors of short RNAs were
detected in the cytoplasm, suggesting that intron retention
events might correlate with the cellular production of
short, probably non-coding RNAs. Consistent with this
view, we show that the set of retained introns matching
short RNAs was enriched in G and C nucleotides. G- and
C-rich regions are likely to form more stable RNA sec-
ondary structures. In addition to this, we found a number
of known small RNAs in retained introns matching short
transcribed fragments (18 snoRNSs and 1 microRNA in
total). This result further supports our hypothesis that a
subset of retained introns contains small RNAs and calls
for experimental validation of coordination between
splicing regulation of intron retention and production of
particular non-coding RNAs.
Conservation analysis is often used to indicate function-
ality. However, non-coding transcripts, which we have
identiﬁed through consensus splice-sites alone, would be
expected to have a low level of overall sequence conserva-
tion. If conservation exists, for example, at the level of
RNA secondary structure, these sequences may have
undergone divergence, which precludes their detection by
primary sequence conservation alone. Our conservation
analysis, of both tiling array validated unannotated
exons and retained introns, shows a greater number of
sequences conserved in horse, dog and cow than in
mouse and rat. Phylogenetic studies performed in 2001
(75) suggested a common placental ancestor for human
and rodents branching oﬀ from a distinct placental
ancestor for horse, cow and dog. This would imply that
rodents might have lost characteristics which could still be
common to primates and laurasiatheria. However, more
recent phylogenetic analyses from 2007 (76), performed
using whole-genome data, instead resulted in overwhelm-
ing evidence for a human-carnivore clade with the exclu-
sion of rodents. The latter lends support to our results,
which indicates a greater number of human exons and
Retained introns conserved in dog than in rodents.
Concerning conservation in primates alone, as the
human sequences used in this conservation analysis were
validated by tiling array data, it is rather the portion of
exons and retained introns not conserved in the
nonprimate mammalian species, that stand out from the
overall background of conservation in the other model
organism, which may function in a way unique to
primate biology. However, given the a priori high level
of sequence conservation between human, chimp and
rhesus, and the lack of sequenced transcript information
for nonhuman primate model organisms, it is not yet
possible to determine precisely to what extent additional
complexity in alternative splicing detected in human
through novel exons and retained introns may be
spurious or speciﬁc to primates. Notwithstanding the
lack of concrete evidence for primate speciﬁc function,
this study highlights a considerable number of sequences,
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plasm, which could be unique to primate biology.
Ongoing eﬀorts by multiple research teams to determine
levels of alternative splicing in all organisms will contrib-
ute to a comprehensive view of this complex problem.
Each approach will bring in something that another
approach may miss and likewise each approach will
produce its own spurious data. Many eﬀorts have
focused on determining alternatively spliced protein-
coding variants, and our approach expands this eﬀort to
non-protein-coding transcripts which consist of the
majority of alternatively spliced variants. Recent
evidence in the literature, indicating that non-
protein-coding alternatively spliced transcripts may play
an important regulatory function, strengthens this hypoth-
esis. For example, in Drosophila melanogaster it has been
shown that the conservation of short introns and of
splicing can be used to identify spliced, capped and
polyadenylated non-coding mRNA-like transcripts with
low exon sequence conservation (77). Looking for conser-
vation in introns ﬂanking nonconserved unannotated
exons would be a relevant approach. However, bioinfor-
matics can only throw the spotlight onto potentially inter-
esting avenues. The only way to show that the data are not
spurious is to validate individual cases; and indeed, we are
collaborating with groups who are using our data to do
just that. For example, all unannotated exons detected in
Factor VIII by our analysis have been recently validated
in human pulmonary endothelium, all of these exons were
ﬁrst exons (78).
This bioinformatic analysis highlights potential avenues
which merit attention and validation. Together with
the data made available online to the scientiﬁc commu-
nity, we hope that this study will contribute to a more
comprehensive view of alternative splicing, in particular,
to the role of intron retention and the role of novel exons
in new species. Overall, these results reveal new levels of
complexity in the regulation of alternative splicing in
human.
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